A new study has found that patients who take a combination of the cholesterol drugs TriLipix and Crestor improve their heart risk factors more than patients who take the individual medications alone. Researchers studied data on 760 patients and found the TriLipix/Crestor combination was significantly better at lowering bad cholesterol and triglycerides, as well as raising levels of good cholesterol in patients with complex cholesterol disorders. This new finding will be part of the U.S....
Read moreThe JUPITER study has been the subject of countless headlines reporting the unprecedented reduction in heart attacks with the cholesterol... Read more »
People who use statins like Lipitor, Crestor, and Zocor to lower cholesterol do not have a high risk of developing pancreatitis, researchers have... Read more »
AstraZeneca, the company that makes both the heart drug Toprol and the cholesterol-lowering medicine Crestor, has announced that it is expanding a... Read more »
Drugmaker AstraZeneca has started a program that may help Medicare Part D users afford their medications. Beginning November 15, people who use... Read more »
A recent study has shown that a combination of Crestor and Zetia (ezetimibe) helps high-risk patients lower their cholesterol levels better than... Read more »
According to a new study, the cholesterol-lowering drug Crestor cuts the risk of stroke nearly in half in seemingly healthy people. In a trial that... Read more »